Jannet C. Beukema

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer - PORTEC-4a an international, randomised, phase 3 trial.

Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer - PORTEC-4a an international, randomised, phase 3 trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: December 16, 2025

Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial.

Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial.

Journal: The Lancet. Oncology

Published: June 11, 2025

Age-related differences in patient preferences for adjuvant chemotherapy for high-risk endometrial cancer.

Age-related differences in patient preferences for adjuvant chemotherapy for high-risk endometrial cancer.

Journal: Maturitas

Published: February 24, 2025

Cost-effectiveness of a nurse-led sexual rehabilitation intervention for women treated with radiotherapy for gynaecological cancer in a randomized trial.

Cost-effectiveness of a nurse-led sexual rehabilitation intervention for women treated with radiotherapy for gynaecological cancer in a randomized trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: October 18, 2024

Proton Radiotherapy Significantly Reduces Pneumonia in Patients With Esophageal Cancer.

Proton Radiotherapy Significantly Reduces Pneumonia in Patients With Esophageal Cancer.

Journal: International journal of radiation oncology, biology, physics

Published: May 30, 2024

Blood biomarkers for cardiac damage during and after radiotherapy for esophageal cancer: A prospective cohort study.

Blood biomarkers for cardiac damage during and after radiotherapy for esophageal cancer: A prospective cohort study.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: May 24, 2024

Efficacy of a nurse-led sexual rehabilitation intervention for women with gynaecological cancers receiving radiotherapy: results of a randomised trial.

Efficacy of a nurse-led sexual rehabilitation intervention for women with gynaecological cancers receiving radiotherapy: results of a randomised trial.

Journal: British journal of cancer

Published: April 24, 2024

In Reply to Yavas et al.

In Reply to Yavas et al.

Journal: International journal of radiation oncology, biology, physics

Published: August 03, 2021

Late cardiac toxicity of neo-adjuvant chemoradiation in esophageal cancer survivors: A prospective cross-sectional pilot study.

Late cardiac toxicity of neo-adjuvant chemoradiation in esophageal cancer survivors: A prospective cross-sectional pilot study.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: July 29, 2021

Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy study.

Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy study.

Journal: Gynecologic oncology

Published: May 06, 2021

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 23, 2021

Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making.

Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making.

Journal: Gynecologic oncology

Published: January 25, 2021

Showing 1-12 of 37

Last Updated: 09/26/2026